Soonmyoung Paik, M.D. spaik at
Fri Feb 7 22:01:05 EST 1997

Rachel Teitelbaum wrote:
> Actually, in the papers they were taking tumor cells from the host,
> transfecting them with the constuct, and reinjecting them to hosts that
> were syngeneic, that had the same tumor.  They got rejection for the
> reason described, they now could see the tumor as foreign, cause some
> cells had B7.  Has this entered the realm of clinical trials?

I did not read all the threads, but you can find clinical trials 
information from PDQ database available on National Cancer Institute web 
Soon Paik
NSABP Pathology

More information about the Immuno mailing list